Join
Live feed
·
PRReleasevia Quantisnow
Incannex Healthcare Inc. logo

Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes

ByQuantisnow·Wall Street's wire, on your screen.
IXHL· Incannex Healthcare Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IXHL (Incannex Healthcare Inc.) and more on Quantisnow.